+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Collagen & HA-Based Biomaterials Market by Material Type (Collagen, Hyaluronic Acid), Application (Aesthetics, Drug Delivery, Ophthalmology), End User, Source - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887845
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Collagen and hyaluronic acid-based biomaterials are redefining possibilities in tissue engineering and regenerative medicine, offering diverse applications from aesthetics to advanced drug delivery systems. Senior decision-makers can capitalize on these innovations to strengthen market positioning, optimize product portfolios, and align with evolving regulatory and clinical requirements.

Market Snapshot: Collagen & HA-Based Biomaterials Market

The Collagen & HA-Based Biomaterials Market grew from USD 7.58 billion in 2024 to USD 8.09 billion in 2025. It is expected to continue expanding at a CAGR of 6.75%, reaching USD 11.22 billion by 2030.

Scope & Segmentation of the Collagen and Hyaluronic Acid Biomaterials Market

  • Material Types: Collagen (Type I, Type II, Type III) and hyaluronic acid in crosslinked and non-crosslinked forms—including BDDE and PEG crosslinked configurations.
  • Applications: Aesthetic uses (cosmetic implants, dermal fillers, lip augmentation), drug delivery (controlled release, injectable carriers), ophthalmology (corneal repair, vitreous substitutes), orthopedics (cartilage repair, hip/knee osteoarthritis), and wound care (acute and chronic wounds).
  • End Users: Aesthetic clinics, ambulatory surgical centers, hospitals, and research institutes, each presenting unique requirements for regulatory clearance and clinical application.
  • Source Origins: Animal-derived (bovine, marine, porcine) and recombinant (bacterial fermentation, yeast expression) sources, supporting a wide spectrum of immunological profiles and scalability potentials.
  • Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including UK, Germany, France, South Africa, and others); and Asia-Pacific (notably China, India, Japan, and Australia among others).
  • Market Players Analyzed: Key companies include AbbVie Inc., Johnson & Johnson, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Geistlich Pharma AG, Anika Therapeutics, Inc., Merz Pharma GmbH & Co. KGaA, and Bloomage Biotechnology Corporation Limited.

Key Takeaways: Strategic Insights for Decision-Makers

  • Advancements in purification, crosslinking, and recombinant manufacturing are driving widespread adoption across multiple therapeutic areas.
  • Collaborations between biotechnology firms, academic institutions, and contract research organizations are accelerating the translation of biomaterials from lab to clinical practice.
  • The emergence of digital health integration is enabling intelligent biomaterials that can support real-time monitoring and precision drug delivery.
  • Diversification of sourcing strategies and investments in localized biomanufacturing increase resilience against global supply chain interruptions.
  • Varying adoption patterns exist across key regions, requiring a tailored approach to regulatory compliance, distribution, and product adaptation.
  • Leadership in intellectual property and digital platforms supports market differentiation and operational efficiency.

Tariff Impact: Navigating 2025 US Policy Adjustments

The 2025 tariff changes on imported raw materials have created new cost pressures and supply chain complexity for manufacturers reliant on overseas collagen and HA precursors. Strategic responses include renegotiating supply contracts, strengthening domestic supplier relationships, and investing in biomanufacturing capabilities closer to end markets. The transition toward recombinant expression platforms is reducing reliance on tariff-impacted materials and meeting demands for animal-free and traceable biomaterials, although this pathway requires significant investment in fermentation infrastructure. These shifts highlight the ongoing need for adaptive sourcing and risk mitigation strategies.

Methodology & Data Sources

This report employs a multiphase research process, including comprehensive secondary research, primary interviews with industry professionals, and data triangulation techniques. Findings are validated through expert panels and peer reviews, ensuring analytical accuracy and actionable insights.

Why This Report Matters

  • Enables strategic investment and development decisions by providing granular segmentation, technology, and regional analysis specific to collagen and hyaluronic acid biomaterials.
  • Equips decision-makers with insights on evolving regulatory landscapes and supply chain dynamics to maintain competitive advantage.
  • Guides actionable planning by connecting technology trends, regional growth enablers, and competitive positioning strategies in one integrated resource.

Conclusion

This report offers a comprehensive assessment of the collagen and hyaluronic acid biomaterials landscape, emphasizing actionable strategies in a shifting market. Stakeholders can confidently leverage these insights to drive innovation and sustainable growth in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of recombinant human collagen to address animal-derived supply constraints
5.2. Integration of hyaluronic acid-based delivery systems for sustained growth factor release
5.3. Advancements in crosslinking techniques to enhance mechanical strength of HA-collagen scaffolds
5.4. Emergence of injectable collagen-HA hydrogels for minimally invasive tissue regeneration
5.5. Development of customized 3D-printed collagen-HA composite implants for patient-specific defects
5.6. Regulatory approvals driving commercialization of collagen-HA wound care products in key markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Collagen & HA-Based Biomaterials Market, by Material Type
8.1. Introduction
8.2. Collagen
8.2.1. Type I
8.2.2. Type II
8.2.3. Type III
8.3. Hyaluronic Acid
8.3.1. Crosslinked
8.3.1.1. Bdde Crosslinked
8.3.1.2. Peg Crosslinked
8.3.2. Non-Crosslinked
9. Collagen & HA-Based Biomaterials Market, by Application
9.1. Introduction
9.2. Aesthetics
9.2.1. Cosmetic Implants
9.2.2. Dermal Fillers
9.2.3. Lip Augmentation
9.3. Drug Delivery
9.3.1. Controlled Release
9.3.2. Injectable Carriers
9.4. Ophthalmology
9.4.1. Corneal Repair
9.4.2. Vitreous Substitutes
9.5. Orthopedics
9.5.1. Cartilage Repair
9.5.2. Hip Osteoarthritis
9.5.3. Knee Osteoarthritis
9.6. Wound Care
9.6.1. Acute Wounds
9.6.2. Chronic Wounds
10. Collagen & HA-Based Biomaterials Market, by End User
10.1. Introduction
10.2. Aesthetic Clinics
10.3. Ambulatory Surgical Centers
10.4. Hospitals
10.5. Research Institutes
11. Collagen & HA-Based Biomaterials Market, by Source
11.1. Introduction
11.2. Animal Derived
11.2.1. Bovine
11.2.2. Marine
11.2.3. Porcine
11.3. Recombinant
11.3.1. Bacterial Fermentation
11.3.2. Yeast Expression
12. Americas Collagen & HA-Based Biomaterials Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Collagen & HA-Based Biomaterials Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Collagen & HA-Based Biomaterials Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Johnson & Johnson
15.3.3. Medtronic plc
15.3.4. Stryker Corporation
15.3.5. Zimmer Biomet Holdings, Inc.
15.3.6. Smith & Nephew plc
15.3.7. Geistlich Pharma AG
15.3.8. Anika Therapeutics, Inc.
15.3.9. Merz Pharma GmbH & Co. KGaA
15.3.10. Bloomage Biotechnology Corporation Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COLLAGEN & HA-BASED BIOMATERIALS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. COLLAGEN & HA-BASED BIOMATERIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. COLLAGEN & HA-BASED BIOMATERIALS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. COLLAGEN & HA-BASED BIOMATERIALS MARKET: RESEARCHAI
FIGURE 24. COLLAGEN & HA-BASED BIOMATERIALS MARKET: RESEARCHSTATISTICS
FIGURE 25. COLLAGEN & HA-BASED BIOMATERIALS MARKET: RESEARCHCONTACTS
FIGURE 26. COLLAGEN & HA-BASED BIOMATERIALS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COLLAGEN & HA-BASED BIOMATERIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY TYPE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY BDDE CROSSLINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY BDDE CROSSLINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY PEG CROSSLINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY PEG CROSSLINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY NON-CROSSLINKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY NON-CROSSLINKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COSMETIC IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DERMAL FILLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY LIP AUGMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY LIP AUGMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY INJECTABLE CARRIERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY INJECTABLE CARRIERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CORNEAL REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY VITREOUS SUBSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY VITREOUS SUBSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CARTILAGE REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ACUTE WOUNDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CHRONIC WOUNDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETIC CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETIC CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY BOVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MARINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MARINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY BACTERIAL FERMENTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY BACTERIAL FERMENTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY YEAST EXPRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY YEAST EXPRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 171. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 174. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 175. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 176. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 177. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 178. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 179. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 182. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 183. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 184. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 185. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 186. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 187. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 188. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 189. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 190. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 191. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 194. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 195. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 196. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 197. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 198. CANADA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 199. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 202. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 203. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 204. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 205. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 206. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 207. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 212. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 213. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 214. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 215. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 218. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 219. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 224. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 225. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 226. MEXICO COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY WOUND CARE, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ANIMAL DERIVED, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY RECOMBINANT, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY MATERIAL TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY COLLAGEN, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY HYALURONIC ACID, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY CROSSLINKED, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY AESTHETICS, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY DRUG DELIVERY, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY OPHTHALMOLOGY, 2025-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA COLLAGEN & HA-BASED BIOMATERIALS MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Collagen & HA-Based Biomaterials market report include:
  • AbbVie Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
  • Geistlich Pharma AG
  • Anika Therapeutics, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Bloomage Biotechnology Corporation Limited

Table Information